Report Detail
Global Vandetanib Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4753067 |
- 05 October, 2026 |
- Global |
- 83 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Vandetanib Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Vandetanib tablets are a targeted cancer therapy used primarily to treat advanced medullary thyroid carcinoma(MTC).As a tyrosine kinase inhibitor,vandetanib works by blocking several receptor tyrosine kinases involved in tumor growth,blood vessel formation,and cancer cell proliferation.By inhibiting these signaling pathways,vandetanib helps to slow or stop the progression of the cancer.
This report is a detailed and comprehensive analysis for global Vandetanib Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Vandetanib Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Vandetanib Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Vandetanib Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Vandetanib Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vandetanib Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vandetanib Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Sanofi, Lucius Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Vandetanib Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
100mg per Tablet
300mg per Tablet
Market segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Major players covered
AstraZeneca
Sanofi
Lucius Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vandetanib Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vandetanib Tablets, with price, sales quantity, revenue, and global market share of Vandetanib Tablets from 2021 to 2026.
Chapter 3, the Vandetanib Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vandetanib Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Vandetanib Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vandetanib Tablets.
Chapter 14 and 15, to describe Vandetanib Tablets sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Vandetanib Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 100mg per Tablet
- 1.3.3 300mg per Tablet
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Vandetanib Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital and Clinic
- 1.4.3 Retail Pharmacies
- 1.4.4 Other
- 1.5 Global Vandetanib Tablets Market Size & Forecast
- 1.5.1 Global Vandetanib Tablets Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Vandetanib Tablets Sales Quantity (2021-2032)
- 1.5.3 Global Vandetanib Tablets Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 AstraZeneca
- 2.1.1 AstraZeneca Details
- 2.1.2 AstraZeneca Major Business
- 2.1.3 AstraZeneca Vandetanib Tablets Product and Services
- 2.1.4 AstraZeneca Vandetanib Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 AstraZeneca Recent Developments/Updates
- 2.2 Sanofi
- 2.2.1 Sanofi Details
- 2.2.2 Sanofi Major Business
- 2.2.3 Sanofi Vandetanib Tablets Product and Services
- 2.2.4 Sanofi Vandetanib Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Sanofi Recent Developments/Updates
- 2.3 Lucius Pharma
- 2.3.1 Lucius Pharma Details
- 2.3.2 Lucius Pharma Major Business
- 2.3.3 Lucius Pharma Vandetanib Tablets Product and Services
- 2.3.4 Lucius Pharma Vandetanib Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Lucius Pharma Recent Developments/Updates
3 Competitive Environment: Vandetanib Tablets by Manufacturer
- 3.1 Global Vandetanib Tablets Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Vandetanib Tablets Revenue by Manufacturer (2021-2026)
- 3.3 Global Vandetanib Tablets Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Vandetanib Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Vandetanib Tablets Manufacturer Market Share in 2025
- 3.4.3 Top 6 Vandetanib Tablets Manufacturer Market Share in 2025
- 3.5 Vandetanib Tablets Market: Overall Company Footprint Analysis
- 3.5.1 Vandetanib Tablets Market: Region Footprint
- 3.5.2 Vandetanib Tablets Market: Company Product Type Footprint
- 3.5.3 Vandetanib Tablets Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Vandetanib Tablets Market Size by Region
- 4.1.1 Global Vandetanib Tablets Sales Quantity by Region (2021-2032)
- 4.1.2 Global Vandetanib Tablets Consumption Value by Region (2021-2032)
- 4.1.3 Global Vandetanib Tablets Average Price by Region (2021-2032)
- 4.2 North America Vandetanib Tablets Consumption Value (2021-2032)
- 4.3 Europe Vandetanib Tablets Consumption Value (2021-2032)
- 4.4 Asia-Pacific Vandetanib Tablets Consumption Value (2021-2032)
- 4.5 South America Vandetanib Tablets Consumption Value (2021-2032)
- 4.6 Middle East & Africa Vandetanib Tablets Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Vandetanib Tablets Sales Quantity by Type (2021-2032)
- 5.2 Global Vandetanib Tablets Consumption Value by Type (2021-2032)
- 5.3 Global Vandetanib Tablets Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Vandetanib Tablets Sales Quantity by Application (2021-2032)
- 6.2 Global Vandetanib Tablets Consumption Value by Application (2021-2032)
- 6.3 Global Vandetanib Tablets Average Price by Application (2021-2032)
7 North America
- 7.1 North America Vandetanib Tablets Sales Quantity by Type (2021-2032)
- 7.2 North America Vandetanib Tablets Sales Quantity by Application (2021-2032)
- 7.3 North America Vandetanib Tablets Market Size by Country
- 7.3.1 North America Vandetanib Tablets Sales Quantity by Country (2021-2032)
- 7.3.2 North America Vandetanib Tablets Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Vandetanib Tablets Sales Quantity by Type (2021-2032)
- 8.2 Europe Vandetanib Tablets Sales Quantity by Application (2021-2032)
- 8.3 Europe Vandetanib Tablets Market Size by Country
- 8.3.1 Europe Vandetanib Tablets Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Vandetanib Tablets Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Vandetanib Tablets Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Vandetanib Tablets Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Vandetanib Tablets Market Size by Region
- 9.3.1 Asia-Pacific Vandetanib Tablets Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Vandetanib Tablets Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Vandetanib Tablets Sales Quantity by Type (2021-2032)
- 10.2 South America Vandetanib Tablets Sales Quantity by Application (2021-2032)
- 10.3 South America Vandetanib Tablets Market Size by Country
- 10.3.1 South America Vandetanib Tablets Sales Quantity by Country (2021-2032)
- 10.3.2 South America Vandetanib Tablets Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Vandetanib Tablets Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Vandetanib Tablets Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Vandetanib Tablets Market Size by Country
- 11.3.1 Middle East & Africa Vandetanib Tablets Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Vandetanib Tablets Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Vandetanib Tablets Market Drivers
- 12.2 Vandetanib Tablets Market Restraints
- 12.3 Vandetanib Tablets Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Vandetanib Tablets and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Vandetanib Tablets
- 13.3 Vandetanib Tablets Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Vandetanib Tablets Typical Distributors
- 14.3 Vandetanib Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Vandetanib Tablets. Industry analysis & Market Report on Vandetanib Tablets is a syndicated market report, published as Global Vandetanib Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Vandetanib Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
